Viewing nowEsomeprazole Magnesium Trihydrate 20 mg Tablet
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 201508410 · Approved 2015.12.23 · Insurance code 645208920
Treatment of gastroesophageal reflux, gastrointestinal disorders (ulcers, drug-related symptoms, etc.), and Zollinger-Ellison syndrome
This medicine is used to treat gastroesophageal reflux disease and erosive esophagitis, and is effective as a long-term maintenance therapy to prevent recurrences in patients with esophagitis. It also helps in the treatment and prevention of recurrence of peptic ulcers and duodenal ulcers in patients positive for Helicobacter pylori. It is widely utilized to alleviate upper gastrointestinal symptoms caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs), and to treat gastric ulcers, as well as to prevent gastric and duodenal ulcers. It is also used for treatment of Zollinger-Ellison syndrome and for maintenance therapy after the prevention of rebleeding from gastric ulcers or duodenal ulcers. In summary, it is an effective drug for the treatment and prevention of various gastrointestinal-related diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent episodes may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 2) Concomitant antibiotic therapy for eradication of Helicobacter pylori Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4–8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80–160 mg per day. Doses greater than 80 mg per day should be divided into two doses. 6) Maintenance therapy following intravenous induction of prevention of recurrent bleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of recurrent bleeding from gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent episodes may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 3. Children under 12 years of age There is no experience with administration of this drug to children under 12 years of age.
This medicine should not be administered to certain patients. For example, patients who are allergic to this medicine or its ingredients, or who have previously shown allergic reactions to similar medications, should not use this medicine. Additionally, patients allergic to penicillin-based or macrolide antibiotics should avoid concomitant use of this medication during Helicobacter pylori eradication therapy. Patients taking certain cardiac-related medications or those with a history of myocardial infarction should also refrain from using this medicine. Women who are breastfeeding should avoid this medication as it is uncertain whether it is transmitted through breast milk. This medicine contains lactose and should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. While taking this medication, various adverse reactions may occur. Common symptoms include headache, abdominal pain, diarrhea, and nausea, while rare cases have reported decrease in blood cell counts, allergic reactions, liver function abnormalities, skin rashes, and myalgia. In particular, long-term use may lead to electrolyte abnormalities such as hypomagnesemia, so regular monitoring is necessary. Also, as this medication suppresses gastric acid secretion, there may be an increased risk of bacterial infections in the gastrointestinal tract, and hospitalized patients may have an increased risk of diarrhea due to Clostridium difficile infection. There is a high potential for this medicine to interact with other medications, so caution is required during concomitant therapy. For example, drug concentrations may vary when taken with certain antivirals, anticoagulants, anticonvulsants, and antidepressants, so follow your doctor's instructions. During pregnancy, no significant issues have been found in animal studies, but it should be administered with caution in pregnant women, and it is safest to avoid during breastfeeding. In cases of overdose, there is no specific antidote, so treatment should focus on symptomatic management and general care, as this medication is not removed by dialysis. Finally, this medicine should be kept out of the reach of children, and care should be taken not to transfer it to another container as it may adversely affect quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, perceptual disturbances, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia and systemic drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformations, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stool, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, xerostomia, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremor, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, urination abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature, between 1°C and 30°C.
Pink round film-coated tablet
28 tablets (14 tablets/Alu-Alu×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.